EVOQ Therapeutics LLC
EVOQ Therapeutics LLC, based in Ann Arbor, Michigan, is at the forefront of developing innovative immunotherapies aimed at enhancing the lives of individuals suffering from autoimmune diseases. Utilizing their proprietary NanoDisc technology, the company targets the root causes of conditions such as Type 1 diabetes, Celiac disease, and Lupus by restoring the body's native immune tolerance.
Through simple subcutaneous administration, EVOQ's NanoDiscs deliver disease-specific antigens directly to critical immune cells, significantly improving immune responses with up to 30 times greater effectiveness compared to traditional therapies. Their promising preclinical data indicates a new direction for treating autoimmune diseases, emphasizing targeted delivery and enhanced patient outcomes.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
